Cell Therapeutics, Inc. (NASDAQ:CTIC)

Q: Chip, Enjoyed reading  your article about the tremendous growth that CTIC is having during year. Do you feel that CTIC is heading for a reverse split soon? Thanks, Ed A: Hi Ed, Thanks for your question and your interest in SmarTrend.  SmarTrend is a technical analysis tool that uses several proprietary indicators to simultaneously measure price movement in more than 5,000 U.S. stocks, ETFs and market Indexes.  It detects major trends and issues alerts to subscribers when trends change.  Attached is a chart showing our calls on CTIC.  I also attached a chart of the S&P 500 so you can see what a more typical chart looks like.  It is fairly rare for our system to issue only two trend trend alerts in a little more than a year, but then again, it couldn't have really been called much better.  The Downtrend on 6/24/2008 returned 96.5% by the time of the Uptrend issued at $0.15 on 3/23/2009.  That Uptrend has since returned 972.4%.  SmarTrend probably won't be able to see a reverse split coming, but if you're making 1000% it may not be as much of an issue. cticinx